Get involved in ECCO
Written by Karen Ramirez | 11 Apr 2017
Commentary and insights from Dr Filip Baert, (Roeselare, Belgium) and Usha Chauhan (McMaster University, Canada)
BSH 2017: How I treat molecular high-risk myeloma – what can we do, what should we do?
Written by Karen Ramirez | 6 Apr 2017
High-risk multiple myeloma (MM) continues to pose a challenge to haematologists both in terms of diagnostics and therapy. Opening the UK Myeloma Forum at the 2017 BSH annual… read more.
BSH 2017: Are we ready to use minimum residual disease to direct therapy?
Written by Karen Ramirez | 4 Apr 2017
Studies show that MM patients who achieve minimal residual disease on treatment have longer PFS and OS than those who do not…
ECCO 2017: Highlights
Written by Karen Ramirez | 4 Apr 2017
If you missed ECCO this year, or if you attended, but didn’t get to see everything you’d hoped to, listen to the key highlights from Professor Séverine Vermeire… read more.
Vulnerable patients: burning questions in IBD
Written by Karen Ramirez | 30 Mar 2017
An interesting session at ECCO dealt with the patients for whom there is sparce data to guide their treatment – experts in the field gave their guidance to… read more.
New compounds in the treatment of IBD (ECCO 2017)
Written by Karen Ramirez | 17 Mar 2017
Never before in the history of IBD have there been so many promising compounds in the pipeline. In a scientific session dedicated to new compounds, leading investigators discussed… read more.
Clinical trials vs real life
Written by Karen Ramirez | 15 Mar 2017
Dr Filip Baert (Roeselare, Belgium) gives a summary of his session on trial endpoints vs therapeutic objectives. he also discusses the role of ECCO in improving the data generated in… read more.
Predicting disease years before diagnosis
Written by Karen Ramirez | 15 Mar 2017
Predicting disease years before diagnosis is a passion for Professor Jean-Frederic Colombel (Icahn School of Medicine at Mount Sinai, NY, USA). Here he discusses 2 studies presented at… read more.
Is ‘online therapy’ making patients worse?
Written by Karen Ramirez | 13 Mar 2017
Scientists in Sweden are studying whether web-based cognitive behavioural therapy (CBT) is ineffective in some people, potentially making patients worse. The psychologist behind the research say that while… read more.
Post-surgical pain scores improve as analgesic opioid use falls
Written by Karen Ramirez | 27 Feb 2017
Researchers who conducted a retrospective analysis of data from over 100,000 surgical cases in one university health system have reported that patients’ pain scores improved when physicians administered… read more.
World Health Matters: Researchers explore therapy and outcomes in PTCL
Written by Karen Ramirez | 27 Feb 2017
Dr Andrei Shustov (University of Washington School of Medicine, Seattle, USA) summarises the advances in T-Cell lymphoma therapy at ASH 2016, including long term data in PTCL and ALCL…. read more.
What does 2017 hold for myeloma patients?
Written by Karen Ramirez | 6 Feb 2017
Professor Sagar Lonial (Emory University School of Medicine), Professor Gareth Morgan (UAMS Myeloma Institute) and Professor Graham Jackson (Newcastle) discuss what 2017 might hold for patients and the management of myeloma and… read more.
Subscribe for our mailing list
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
This website uses cookies to enhance your browsing experience, analyse site traffic, and personalise content. By clicking “Accept” you consent to the use of all cookies. You can manage your preferences or withdraw consent at any time by visiting our cookie settings.
Functional Always active
Preferences
Statistics
Marketing
If you’re a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

